BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Alhakamy NA, Badr-Eldin SM, A Fahmy U, Alruwaili NK, Awan ZA, Caruso G, Alfaleh MA, Alaofi AL, Arif FO, Ahmed OAA, Alghaith AF. Thymoquinone-Loaded Soy-Phospholipid-Based Phytosomes Exhibit Anticancer Potential against Human Lung Cancer Cells. Pharmaceutics 2020;12:E761. [PMID: 32806507 DOI: 10.3390/pharmaceutics12080761] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 7.7] [Reference Citation Analysis]
Number Citing Articles
1 Frosi I, Ferron L, Colombo R, Papetti A. Natural carriers: Recent advances in their use to improve the stability and bioaccessibility of food active compounds. Critical Reviews in Food Science and Nutrition 2022. [DOI: 10.1080/10408398.2022.2157371] [Reference Citation Analysis]
2 Ansari A, Hussain A, Wadekar R, Altamimi MA, Malik A, Mujtaba MA, Ansari MY, Siddique MUM, Goyal SN. Nanovesicles based drug targeting to control tumor growth and metastasis. Advances in Cancer Biology - Metastasis 2022. [DOI: 10.1016/j.adcanc.2022.100083] [Reference Citation Analysis]
3 Alhakamy NA, Fahmy UA. Exploring cytotoxicity of cordycepin loaded nanovesicles against (HCT116) colon cancer cells: Optimization and cellular evaluation. Biomed Pharmacother 2022;154:113619. [PMID: 36081285 DOI: 10.1016/j.biopha.2022.113619] [Reference Citation Analysis]
4 Badr-Eldin SM, Aldawsari HM, Fahmy UA, Ahmed OAA, Alhakamy NA, Al-Hejaili OD, Alhassan AA, Ammari GA, Alhazmi SI, Alawadi RM, Bakhaidar R, Alamoudi AJ, Neamatallah T, Tima S. Optimized Apamin-Mediated Nano-Lipidic Carrier Potentially Enhances the Cytotoxicity of Ellagic Acid against Human Breast Cancer Cells. Int J Mol Sci 2022;23:9440. [PMID: 36012704 DOI: 10.3390/ijms23169440] [Reference Citation Analysis]
5 Waghule T, Saha RN, Alexander A, Singhvi G. Tailoring the multi-functional properties of phospholipids for simple to complex self-assemblies. J Control Release 2022;349:460-74. [PMID: 35841998 DOI: 10.1016/j.jconrel.2022.07.014] [Reference Citation Analysis]
6 Kirdeeva Y, Fedorova O, Daks A, Barlev N, Shuvalov O. How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology? Pharmaceuticals 2022;15:868. [DOI: 10.3390/ph15070868] [Reference Citation Analysis]
7 Saddiq AA, El-far AH, Mohamed Abdullah SA, Godugu K, Almaghrabi OA, Mousa SA. Curcumin, thymoquinone, and 3, 3′-diindolylmethane combinations attenuate lung and liver cancers progression. Front Pharmacol 2022;13:936996. [DOI: 10.3389/fphar.2022.936996] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Alam M, Alam S, Shamsi A, Adnan M, Elasbali AM, Al-Soud WA, Alreshidi M, Hawsawi YM, Tippana A, Pasupuleti VR, Hassan MI. Bax/Bcl-2 Cascade Is Regulated by the EGFR Pathway: Therapeutic Targeting of Non-Small Cell Lung Cancer. Front Oncol 2022;12:869672. [PMID: 35402265 DOI: 10.3389/fonc.2022.869672] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 6.0] [Reference Citation Analysis]
9 Alam M, Hasan GM, Ansari MM, Sharma R, Yadav DK, Hassan MI. Therapeutic implications and clinical manifestations of thymoquinone. Phytochemistry 2022. [DOI: 10.1016/j.phytochem.2022.113213] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
10 Al-Rabia MW, Alhakamy NA, Rizg WY, Alghaith AF, Ahmed OAA, Fahmy UA. Boosting curcumin activity against human prostatic cancer PC3 cells by utilizing scorpion venom conjugated phytosomes as promising functionalized nanovesicles. Drug Deliv 2022;29:807-20. [PMID: 35266425 DOI: 10.1080/10717544.2022.2048133] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
11 Alhakamy NA, Okbazghi SZ, A. Alfaleh M, H. Abdulaal W, Bakhaidar RB, Alselami MO, Zahrani MA, Alqarni HM, F. Alghaith A, Alshehri S, Badr-eldin SM, Aldawsari HM, Al-hejaili OD, Aldhabi BM, Mahdi WA. Wasp venom peptide improves the proapoptotic activity of alendronate sodium in A549 lung cancer cells. PLoS ONE 2022;17:e0264093. [DOI: 10.1371/journal.pone.0264093] [Reference Citation Analysis]
12 Karpuz M, İlhan M, Gültekin HE, Ozgenc E, Şenyiğit Z, Atlihan-gundogdu E. Nanovesicles for tumor-targeted drug delivery. Applications of Nanovesicular Drug Delivery 2022. [DOI: 10.1016/b978-0-323-91865-7.00017-1] [Reference Citation Analysis]
13 Limongi T, Susa F, Marini M, Allione M, Torre B, Pisano R, di Fabrizio E. Lipid-Based Nanovesicular Drug Delivery Systems. Nanomaterials (Basel) 2021;11:3391. [PMID: 34947740 DOI: 10.3390/nano11123391] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
14 Asfour HZ, Fahmy UA, Alharbi WS, Almehmady AM, Alamoudi AJ, Tima S, Mansouri RA, Omar UM, Ahmed OAA, Zakai SA, Aldarmahi AA, Bagalagel A, Diri R, Alhakamy NA. Phyto-Phospholipid Conjugated Scorpion Venom Nanovesicles as Promising Carrier That Improves Efficacy of Thymoquinone against Adenocarcinoma Human Alveolar Basal Epithelial Cells. Pharmaceutics 2021;13:2144. [PMID: 34959424 DOI: 10.3390/pharmaceutics13122144] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
15 Tabassum S, Rosli N, Ichwan SJA, Mishra P. Thymoquinone and its pharmacological perspective: A review. Pharmacological Research - Modern Chinese Medicine 2021;1:100020. [DOI: 10.1016/j.prmcm.2021.100020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
16 Kammoun AK, Khedr A, Hegazy MA, Almalki AJ, Hosny KM, Abualsunun WA, Murshid SSA, Bakhaidar RB. Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole‒clove oil transferosomal nanoparticles. Drug Deliv 2021;28:2229-40. [PMID: 34668818 DOI: 10.1080/10717544.2021.1992040] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Hani U, M. YB, Wahab S, Siddiqua A, Osmani RAM, Rahamathulla M. A Comprehensive Review of Current Perspectives on Novel Drug Delivery Systems and Approaches for Lung Cancer Management. J Pharm Innov. [DOI: 10.1007/s12247-021-09582-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Alhakamy NA, Al-Rabia MW, Md S, Sirwi A, Khayat SS, AlOtaibi SS, Hakami RA, Al Sadoun H, Eldakhakhny BM, Abdulaal WH, Aldawsari HM, Badr-Eldin SM, Elfaky MA. Development and Optimization of Luliconazole Spanlastics to Augment the Antifungal Activity against Candida albicans. Pharmaceutics 2021;13:977. [PMID: 34203359 DOI: 10.3390/pharmaceutics13070977] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Pal RR, Rajpal V, Singh P, Saraf SA. Recent Findings on Thymoquinone and Its Applications as a Nanocarrier for the Treatment of Cancer and Rheumatoid Arthritis. Pharmaceutics 2021;13:775. [PMID: 34067322 DOI: 10.3390/pharmaceutics13060775] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
20 Radwan MF, El-Moselhy MA, Alarif WM, Orif M, Alruwaili NK, Alhakamy NA. Optimization of Thymoquinone-Loaded Self-Nanoemulsion for Management of Indomethacin-Induced Ulcer. Dose Response 2021;19:15593258211013655. [PMID: 33994890 DOI: 10.1177/15593258211013655] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Gaafar PME, El-Salamouni NS, Farid RM, Hazzah HA, Helmy MW, Abdallah OY. Pegylated liquisomes: A novel combined passive targeting nanoplatform of L-carnosine for breast cancer. Int J Pharm 2021;602:120666. [PMID: 33933646 DOI: 10.1016/j.ijpharm.2021.120666] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Almajali B, Al-Jamal HAN, Taib WRW, Ismail I, Johan MF, Doolaanea AA, Ibrahim WN. Thymoquinone, as a Novel Therapeutic Candidate of Cancers. Pharmaceuticals (Basel) 2021;14:369. [PMID: 33923474 DOI: 10.3390/ph14040369] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 7.0] [Reference Citation Analysis]
23 Antal DS, Ardelean F. Challenges in the nanoscale delivery systems development in the pharmaceutical and nutraceutical markets. Mitochondrial Dysfunction and Nanotherapeutics 2021. [DOI: 10.1016/b978-0-323-85666-9.00014-0] [Reference Citation Analysis]
24 Alkhalidi HM, Hosny KM, Rizg WY. Oral Gel Loaded by Fluconazole‒Sesame Oil Nanotransfersomes: Development, Optimization, and Assessment of Antifungal Activity. Pharmaceutics 2020;13:E27. [PMID: 33375740 DOI: 10.3390/pharmaceutics13010027] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
25 Fahmy UA, Fahmy O, Alhakamy NA. Optimized Icariin Cubosomes Exhibit Augmented Cytotoxicity against SKOV-3 Ovarian Cancer Cells. Pharmaceutics 2020;13:E20. [PMID: 33374293 DOI: 10.3390/pharmaceutics13010020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]